Companies

Allogene Therapeutics, Inc. (ALLO) SEC filings

CIK 0001737287 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2021
Revenue (USD)095000156000
Net income (USD)-340.4 M-184.6 M
Diluted EPS (USD/shares)-0.87-2.09-2.38

Latest filings

FiledFormDescriptionPeriod
2026-09-30SCHEDULE 13D/ASCHEDULE 13D/A
2026-09-028-K8-K items 5.022026-08-31
2026-08-254FORM 42026-08-21
2026-08-21144144
2026-08-20EFFECTEFFECT items ,,
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12S-3S-3
2026-08-1210-Q10-Q2026-06-30
2026-08-128-K8-K items 2.02,9.012026-08-12
2026-08-07SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-07SCHEDULE 13GSCHEDULE 13G
2026-07-064FORM 42026-07-01
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-234FORM 42026-06-18
2026-06-228-K8-K items 5.07,8.012026-06-18
2026-06-22424B5424B5
2026-05-28DEFA14ADEFA14A
2026-05-288-K8-K items 5.022026-05-28
2026-05-21DEFA14ADEFA14A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 243, 8-K 84, 144 40, 3 27, 10-Q 24, SC 13G/A 20, SCHEDULE 13G/A 19, SC 13G 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ALLO (0.002 USD), /gw/filings/filings?ticker=ALLO&form=8-K, /gw/filings/facts?ticker=ALLO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange